NovaBridge Biosciences (NBP) Return on Sales (2020 - 2023)
NovaBridge Biosciences (NBP) reported Return on Sales of 0.79% for Q3 2023, down 62.73% on a QoQ basis from 2.13% in Q2 2023.
NovaBridge Biosciences (NBP) has 2 years of Return on Sales data on file, last reported at 0.79% in Q3 2023.
- Quarterly Return on Sales changed N/A year-over-year to 0.79% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 0.29% (changed N/A YoY) and the FY2023 annual result came in at 0.33%, up 116.0% from the prior year.
- Return on Sales slipped to 0.79% in Q3 2023 per NBP's latest filing, from 2.13% in the prior quarter.
- Across five years, Return on Sales topped out at 39.34% in Q4 2020 and bottomed at 0.79% in Q3 2023.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 0.79% |
| Jun 30, 2023 | 2.13% |
| Dec 31, 2020 | 39.34% |